368 related articles for article (PubMed ID: 19955220)
1. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
Rutanen J; Rissanen TT; Markkanen JE; Gruchala M; Silvennoinen P; Kivelä A; Hedman A; Hedman M; Heikura T; Ordén MR; Stacker SA; Achen MG; Hartikainen J; Ylä-Herttuala S
Circulation; 2004 Mar; 109(8):1029-35. PubMed ID: 14967735
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
Lähteenvuo JE; Lähteenvuo MT; Kivelä A; Rosenlew C; Falkevall A; Klar J; Heikura T; Rissanen TT; Vähäkangas E; Korpisalo P; Enholm B; Carmeliet P; Alitalo K; Eriksson U; Ylä-Herttuala S
Circulation; 2009 Feb; 119(6):845-56. PubMed ID: 19188502
[TBL] [Abstract][Full Text] [Related]
4. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
5. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.
Askari A; Unzek S; Goldman CK; Ellis SG; Thomas JD; DiCorleto PE; Topol EJ; Penn MS
J Am Coll Cardiol; 2004 May; 43(10):1908-14. PubMed ID: 15145120
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
[TBL] [Abstract][Full Text] [Related]
8. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
Bry M; Kivelä R; Holopainen T; Anisimov A; Tammela T; Soronen J; Silvola J; Saraste A; Jeltsch M; Korpisalo P; Carmeliet P; Lemström KB; Shibuya M; Ylä-Herttuala S; Alhonen L; Mervaala E; Andersson LC; Knuuti J; Alitalo K
Circulation; 2010 Oct; 122(17):1725-33. PubMed ID: 20937974
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer.
Kinnunen K; Korpisalo P; Rissanen TT; Heikura T; Viita H; Uusitalo H; Ylä-Herttuala S
Acta Physiol (Oxf); 2006 Aug; 187(4):447-57. PubMed ID: 16866776
[TBL] [Abstract][Full Text] [Related]
11. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
Rissanen TT; Korpisalo P; Markkanen JE; Liimatainen T; Ordén MR; Kholová I; de Goede A; Heikura T; Gröhn OH; Ylä-Herttuala S
Circulation; 2005 Dec; 112(25):3937-46. PubMed ID: 16344386
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds.
Kumar I; Staton CA; Cross SS; Reed MW; Brown NJ
Br J Surg; 2009 Dec; 96(12):1484-91. PubMed ID: 19918856
[TBL] [Abstract][Full Text] [Related]
13. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
14. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
15. AdVEGF-B186 and AdVEGF-DΔNΔC induce angiogenesis and increase perfusion in porcine myocardium.
Nurro J; Halonen PJ; Kuivanen A; Tarkia M; Saraste A; Honkonen K; Lähteenvuo J; Rissanen TT; Knuuti J; Ylä-Herttuala S
Heart; 2016 Nov; 102(21):1716-1720. PubMed ID: 27173504
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
17. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.
Korpisalo P; Hytönen JP; Laitinen JT; Laidinen S; Parviainen H; Karvinen H; Siponen J; Marjomäki V; Vajanto I; Rissanen TT; Ylä-Herttuala S
Eur Heart J; 2011 Jul; 32(13):1664-72. PubMed ID: 21138938
[TBL] [Abstract][Full Text] [Related]
18. Unique signal transduction of the VEGF family members VEGF-A and VEGF-E.
Shibuya M
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1161-6. PubMed ID: 19909239
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
[TBL] [Abstract][Full Text] [Related]
20. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts.
Payne TR; Oshima H; Okada M; Momoi N; Tobita K; Keller BB; Peng H; Huard J
J Am Coll Cardiol; 2007 Oct; 50(17):1677-84. PubMed ID: 17950150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
